These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39334061)
21. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging. Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508 [TBL] [Abstract][Full Text] [Related]
22. Fully automated VMAT treatment planning for advanced-stage NSCLC patients. Della Gala G; Dirkx MLP; Hoekstra N; Fransen D; Lanconelli N; van de Pol M; Heijmen BJM; Petit SF Strahlenther Onkol; 2017 May; 193(5):402-409. PubMed ID: 28314877 [TBL] [Abstract][Full Text] [Related]
23. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer. Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284 [TBL] [Abstract][Full Text] [Related]
24. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer. Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412 [TBL] [Abstract][Full Text] [Related]
25. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288 [TBL] [Abstract][Full Text] [Related]
26. Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789 [TBL] [Abstract][Full Text] [Related]
27. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate. Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833 [TBL] [Abstract][Full Text] [Related]
28. Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer. Vieillot S; Azria D; Lemanski C; Moscardo CL; Gourgou S; Dubois JB; Aillères N; Fenoglietto P Radiat Oncol; 2010 Oct; 5():92. PubMed ID: 20942958 [TBL] [Abstract][Full Text] [Related]
29. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer]. Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277 [TBL] [Abstract][Full Text] [Related]
30. Association between tumor morphology and dosimetric parameters of organs at risk after intensity-modulated radiotherapy in esophagus cancer. Li F; Luo Y; Chen J; He L; Liang Y; Lai J; Guo F J Appl Clin Med Phys; 2022 Jul; 23(7):e13612. PubMed ID: 35635800 [TBL] [Abstract][Full Text] [Related]
31. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer. Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871 [TBL] [Abstract][Full Text] [Related]
32. Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers. Ding XP; Zhang J; Li BS; Li HS; Wang ZT; Yi Y; Sun HF; Wang DQ Asian Pac J Cancer Prev; 2012; 13(1):319-23. PubMed ID: 22502693 [TBL] [Abstract][Full Text] [Related]
33. Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study. de Figueiredo BH; Antoine M; Trouette R; Lagarde P; Petit A; Lamare F; Hatt M; Fernandez P Radiat Oncol; 2014 Dec; 9():300. PubMed ID: 25534014 [TBL] [Abstract][Full Text] [Related]
34. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer. Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608 [TBL] [Abstract][Full Text] [Related]
35. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors. Simeonova A; Abo-Madyan Y; El-Haddad M; Welzel G; Polednik M; Boggula R; Wenz F; Lohr F Radiother Oncol; 2012 Feb; 102(2):268-73. PubMed ID: 22100654 [TBL] [Abstract][Full Text] [Related]
36. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers. Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511 [TBL] [Abstract][Full Text] [Related]
37. A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT. Zhao H; He M; Cheng G; Han D; Wu N; Shi D; Zhao Z; Jin J Radiat Oncol; 2015 Nov; 10():231. PubMed ID: 26577189 [TBL] [Abstract][Full Text] [Related]
38. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826 [TBL] [Abstract][Full Text] [Related]
39. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery. Zhang F; Zheng M J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607 [TBL] [Abstract][Full Text] [Related]
40. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study. Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]